Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 6491908

Selective elimination of T cells that recognize specific preselected targets

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6479465

Methods of treating colitis using STAT-4 anti-sense oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6479286

Methods and compositions for making dendritic cells from expanded populations of monocytes

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6476201

Methods for the production of non-covalently complexed and multivalent proteosome sub-unit

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6475741

Neutrophil chemotactic factor cloned cDNA and monoclonal antibodies thereto

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6475527

Use of chlorate ion or preparations thereof for reduction of food borne pathogens

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6472438

Active topical skin protectants containing S-330

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6472437

Active topical skin protectants

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6469049

Method of treating, preventing or inhibiting central nervous system injuries and diseases

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6468983

RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6468524

AAV4 vector and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6458590

Methods and compositions for treatment of restenosis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6451763

Retinal pigmented epithelium derived neurotrophic factor and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6451309

Prophylactic and therapeutic monoclonal antibodies

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6448245

Methods of and compounds for inhibiting calpains

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6447796

Sustained release hydrophobic bioactive PLGA microspheres

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6444445

Live vaccine against Brucellosis

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6441156

Calcium channel compositions and methods of use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6437005

Active topical skin protectants using polymer coated metal alloys

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6433023

Compositions having anti-leishmanial activity

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6432434

Treatment of and/or prophylaxis against brain and spinal cord injury

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6432408

Swine hepatitis E virus and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6429232

Method of treating atherosclerosis or restenosis using microtubule stabilizing agent

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 06 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6428790

Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 06 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)